Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
3.150
+0.610 (24.02%)
Mar 23, 2026, 4:00 PM EDT - Market closed
Serina Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Serina Therapeutics stock has a target of 15, which predicts a 376.19% increase from the current stock price of 3.15.
Price Target: $15 (+376.19%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 28, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Serina Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +376.19% | Aug 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $15 | Strong Buy | Initiates | $15 | +376.19% | Jul 14, 2025 |
| Jones Trading | Jones Trading | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +249.21% | Mar 11, 2025 |
Financial Forecast
Revenue This Year
131.30K
from 56.00K
Increased by 134.46%
Revenue Next Year
n/a
from 131.30K
EPS This Year
-2.03
from -1.51
EPS Next Year
-1.82
from -2.03
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 136,500 | n/a | ||||
| Avg | 131,300 | n/a | ||||
| Low | 127,400 | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 143.8% | - | ||||
| Avg | 134.5% | - | ||||
| Low | 127.5% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.11 | -1.88 | ||||
| Avg | -2.03 | -1.82 | ||||
| Low | -1.97 | -1.78 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.